Daisho Hirota

603 total citations
6 papers, 519 citations indexed

About

Daisho Hirota is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cellular and Molecular Neuroscience. According to data from OpenAlex, Daisho Hirota has authored 6 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Surgery and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Daisho Hirota's work include Diabetes Treatment and Management (3 papers), Neuropeptides and Animal Physiology (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (1 paper). Daisho Hirota is often cited by papers focused on Diabetes Treatment and Management (3 papers), Neuropeptides and Animal Physiology (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (1 paper). Daisho Hirota collaborates with scholars based in Japan. Daisho Hirota's co-authors include Satoshi Miyamoto, Nobuo Kajitani, Kenichi Shikata, Ryo Kodera, Hirofumi Makino, Hitomi Kataoka, Chikage Sato, Motofumi Sasaki, Soichi Nishishita and Daisuke Ogawa and has published in prestigious journals such as Diabetes, Biochemical and Biophysical Research Communications and Diabetologia.

In The Last Decade

Daisho Hirota

6 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daisho Hirota Japan	6	327	162	130	103	77	6	519
Ryo Kodera Japan	10	372 1.1×	188 1.2×	170 1.3×	138 1.3×	87 1.1×	16	648
Nobuo Kajitani Japan	9	340 1.0×	161 1.0×	168 1.3×	127 1.2×	94 1.2×	10	640
Chikage Sato Japan	8	290 0.9×	146 0.9×	169 1.3×	114 1.1×	47 0.6×	9	551
Hidemitsu Sakagami Japan	8	206 0.6×	182 1.1×	206 1.6×	69 0.7×	42 0.5×	13	515
Yasutaka Takeda Japan	9	231 0.7×	181 1.1×	171 1.3×	45 0.4×	35 0.5×	20	454
Soichi Nishishita Japan	5	266 0.8×	136 0.8×	103 0.8×	91 0.9×	45 0.6×	11	406
Kumiko Kaifu Japan	12	194 0.6×	86 0.5×	88 0.7×	81 0.8×	30 0.4×	15	426
Taishan Zheng China	14	207 0.6×	214 1.3×	344 2.6×	37 0.4×	50 0.6×	32	662
F. Ravandi Kashani Germany	9	230 0.7×	129 0.8×	161 1.2×	18 0.2×	29 0.4×	17	497
Shinji Odori Japan	10	225 0.7×	144 0.9×	215 1.7×	49 0.5×	69 0.9×	11	566

Countries citing papers authored by Daisho Hirota

Since Specialization

Citations

This map shows the geographic impact of Daisho Hirota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisho Hirota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisho Hirota more than expected).

Fields of papers citing papers by Daisho Hirota

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisho Hirota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisho Hirota. The network helps show where Daisho Hirota may publish in the future.

Co-authorship network of co-authors of Daisho Hirota

This figure shows the co-authorship network connecting the top 25 collaborators of Daisho Hirota. A scholar is included among the top collaborators of Daisho Hirota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisho Hirota. Daisho Hirota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Kodera, Ryo, Kenichi Shikata, Satoshi Miyamoto, et al.. (2013). Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes. Biochemical and Biophysical Research Communications. 443(3). 828–833. 84 indexed citations

2.

Katayama, Akihiro, Hirofumi Noguchi, Takashi Kuise, et al.. (2013). Comparison of New Preservation Solutions, HN-1 and University of Wisconsin Solution, in Pancreas Preservation for Porcine Islet Isolation. PubMed. 6(1-2). 3–8. 7 indexed citations

3.

Katsuyama, Takayuki, Haruhito A. Uchida, Yoshinobu Maeda, et al.. (2013). Large Vessel Vasculitis with Myelodysplastic Syndrome. Internal Medicine. 53(1). 63–66. 5 indexed citations

4.

Miyamoto, Satoshi, Kenichi Shikata, Kyoko Miyasaka, et al.. (2012). Cholecystokinin Plays a Novel Protective Role in Diabetic Kidney Through Anti-inflammatory Actions on Macrophage. Diabetes. 61(4). 897–907. 60 indexed citations

5.

Kodera, Ryo, Kenichi Shikata, Hitomi Kataoka, et al.. (2011). Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes. Diabetologia. 54(4). 965–978. 337 indexed citations

6.

Sato, Chikage, Kenichi Shikata, Daisho Hirota, et al.. (2010). P-Selectin Glycoprotein Ligand-1 Deficiency Is Protective Against Obesity-Related Insulin Resistance. Diabetes. 60(1). 189–199. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact